English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04894591 /

JZP712-402 EMERGE

Phase IV Observational Study To Collect Safety And Outcome Data In Real-World Setting In Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca (EMERGE 402)

DISEASE GROUP:
Lung Cancer Clinical Trials
current phase:
N/A
STUDY STATUS:
Accepting Patients
Location:
Freehold, NJ, Little Silver,NJ
For More information: